CLSA lifts target for Lonza Group stock to CHF 778

Published on 10/27/2026 at 15:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza guides 11.00-12.00 percent growth in 2026. Lonza Group stock costs EUR 686.80 on October 27, 2026, 0.23 percent above Xetra close.

CLSA target and growth outlook

CLSA raised its Lonza target from CHF 759.00 to CHF 778.00 on October 16, 2026.
Lonza reaffirmed 11.00-12.00 percent constant-currency sales growth and a 33.00-34.00 percent core EBITDA margin for fiscal year 2026 on October 14, 2026.
Lonza Group stock costs EUR 686.80 at Lang & Schwarz on October 27, 2026 at 3:43 p.m. CET, 0.23 percent above the Xetra close of October 26, 2026.

Lonza Group, CH0013841017, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) became the subject of a higher analyst valuation when CLSA lifted its price target from CHF 759.00 to CHF 778.00 on October 16, 2026, according to Boerse Express. Lonza Group stock was trading at EUR 686.80 at Lang & Schwarz on October 27, 2026 at 3:43 p.m. CET, 0.23 percent above the Xetra close of October 26, 2026 at EUR 685.20.

CLSA raises its valuation bar

CLSA kept its Accumulate rating while raising the target by CHF 19.00, a 2.50 percent increase from CHF 759.00. The target was 22.87 percent above Lonza's CHF 633.20 primary-market price at 3:37 p.m. CET on October 27, 2026. That comparison puts the analyst view above the company's latest SIX quotation, while the euro quotation is a separate German-market reference.

Lonza's current operating outlook provides the main fundamental counterweight to the target revision. In its October 14, 2026 update, Lonza said third-quarter performance was in line with expectations and reaffirmed fiscal-year 2026 constant-currency sales growth of 11.00-12.00 percent and a core EBITDA margin of 33.00-34.00 percent.

What does the 2026 outlook imply?

The figures separate the near-term forecast from the longer-term ambition. Lonza's medium-term model calls for 10.00-13.00 percent average organic constant-currency sales growth and a core EBITDA margin in the high thirties, while the fiscal-year 2026 margin target remains 33.00-34.00 percent. Reuters reported these targets on October 14, 2026 and said the planned USD 3.00 billion Capsules and Health Ingredients transaction was expected to close by the end of 2026.

Stock position and next date

On the SIX Swiss Exchange, Lonza's CHF 633.20 price on October 27, 2026 stood 0.47 percent below its CHF 636.20 52-week high and 39.28 percent above its CHF 454.60 52-week low. The market capitalization was CHF 44.2 billion on the same date. The next earnings report is scheduled for January 27, 2027, according to TradingView.

Lonza stock at a glance

The immediate market signal is modest beside the analyst revision: the euro quotation was EUR 1.60 above the prior Xetra close, equivalent to 0.23 percent. Investors therefore have two dated markers to separate, the higher CHF 778.00 target from October 16 and the confirmed fiscal-year 2026 operating outlook from October 14.

The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.